Senseonics (NYSE:SENS) announced that it made equity grants to new employees under its 2019 inducement plan.
Germantown, Maryland-based Senseonics, which develops the Eversense family continuous glucose monitoring (CGM) systems, including the latest-generation Eversense E3 180-day CGM, made the equity grants in accordance with the NYSE American Company Guide Section 711(a).
Get the full story at our sister site, Drug Delivery Business News.